| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |